Secaucus, NJ, Jan. 30, 2018 -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise content management solution ranked number one among Document Management and Imaging (DMI) software products in the 2018 Best in KLAS: Software & Services report, an independent ranking based on customer feedback from healthcare information technology providers. ChartMaxx secured the highest overall score and product quality rating in the DMI category.
|
||||||
2018 marks the tenth time ChartMaxx has ranked number one in the Best in KLAS report, making it the most frequently awarded product in the DMI category. DMI software is used to scan, create, archive, streamline workflows and validate electronically stored content for hospitals and health organizations to complement their EHR, enterprise resource planning (ERP), and financial systems where additional enterprise data needs to be captured and accessed for better patient care.
The category leader designation is reserved for vendor solutions that lead select markets in which at least two products meet a minimum level of KLAS konfidence. These vendors earned the title of Category Leader in the 2018 Best in KLAS: Software & Services report—a top honor for helping healthcare professionals deliver better patient care.
“Category Leader is more than a ranking. It is a recognition of vendors committed to delivering superior solutions,” said Adam Gale, president of KLAS. “It gives voice to thousands of providers who are demanding better performance, usability and interoperability in healthcare technology.”
The ChartMaxx product suite has helped more than 300 hospitals and integrated healthcare delivery networks (IDNs) improve their content management for more than 20 years, enabling organizations to achieve enterprise-wide content management to promote better patient care, enhance operational efficiencies, and reduce the overall cost of the business of healthcare. Quest’s award-winning implementation, integration, consulting and process re-engineering services in support of ChartMaxx help healthcare organizations define, streamline and automate departmental workflows, improving efficiencies as well as clinical care.
"ChartMaxx continues to set the gold standard in DMI, and in 2018 aims to take our innovative offering even higher with an expanded range of capabilities that will include process automation applications to streamline operations and configurations that enable customers to reduce infrastructure and support costs,” said Tom Romeo, general manager, healthcare information technology, Quest Diagnostics. "With these new solutions, healthcare organizations will be able to capture and automate their data and content better than ever, which is critical given today’s data-driven healthcare industry. The Category Leader distinction is an honor that affirms our commitment to creating innovative solutions that help healthcare professionals use diagnostic insights and other healthcare information to improve patient care.”
The ChartMaxx enterprise content management solution is part of the QuestQuanum™ health technology and data analytics portfolio from Quest Diagnostics. Quanum solutions strive to connect healthcare organizations, physicians, and patients to improve access to information and insights. Quanum includes an analytics suite and clinical and financial suite, and has solutions spanning eLabs, ePrescribing, Interactive Insights, Electronic Health Record, Practice Management and Revenue Cycle Management.
ChartMaxx will be showcased with the Quanum portfolio at the Quest Diagnostics exhibit (5450) during the 2018 HIMSS Conference & Exhibition, March 5-9, in Las Vegas.
*2002, 2004-2006, 2008-2011, 2013, 2018 Best in KLAS: Software and Services report
About KLAS
KLAS is a data-driven company on a mission to improve the world’s healthcare by enabling provider and payer voices to be heard and counted. Working with thousands of healthcare professionals, KLAS collects insights on software, services and medical equipment to deliver reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly reflects the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit www.KLASresearch.com.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. Additional company information is available at QuestDiagnostics.com and product information available at www.ChartMaxx.com
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/98d83f9c-dc7d-406c-8c52-34be39dd5b61
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/509b1a43-8a54-4c52-a7aa-9260e19c0ac1
Kim Gorode Quest Diagnostics, Media Relations 973-520-2800 Shawn Bevec Quest Diagnostics, Investor Relations 973-520-2900


Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Amazon Explores AI Content Marketplace With Media Publishers
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 



